Corrects company name in paragraph 1
May 21 (Reuters) - Moderna MRNA.O said on Wednesday it had withdrawn the pending application for its flu and COVID combination vaccine candidate for adults aged 50 years and older.
The company would resubmit the application later this year with vaccine efficacy data from the late-stage trial of its experimental seasonal influenza vaccine, it said.
(Reporting by Manas Mishra in Bengaluru; Editing by Anil D'Silva)
((Manas.Mishra@thomsonreuters.com; www.twitter.com/Manaswrites15;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。